House & Home
Thu, October 21, 2010Wed, October 20, 2010Tue, October 19, 2010Mon, October 18, 2010Fri, October 15, 2010Thu, October 14, 2010Wed, October 13, 2010Tue, October 12, 2010Mon, October 11, 2010Sun, October 10, 2010Fri, October 8, 2010Thu, October 7, 2010Wed, October 6, 2010Tue, October 5, 2010Mon, October 4, 2010Sun, October 3, 2010Sat, October 2, 2010Fri, October 1, 2010Thu, September 30, 2010Wed, September 29, 2010Tue, September 28, 2010Mon, September 27, 2010Fri, September 24, 2010Thu, September 23, 2010Wed, September 22, 2010Tue, September 21, 2010Mon, September 20, 2010Fri, September 17, 2010Thu, September 16, 2010Wed, September 15, 2010Tue, September 14, 2010Mon, September 13, 2010Sat, September 11, 2010Fri, September 10, 2010Thu, September 9, 2010Wed, September 8, 2010Tue, September 7, 2010MARY ANN GRAY, PH.D., JOINS THE BOARD OF DIRECTORS OF SENOMYX, INC.
//house-home.news-articles.net/content/2010/09/2 .. joins-the-board-of-directors-of-senomyx-inc.html
Published in House and Home on Tuesday, September 28th 2010 at 5:40 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
SAN DIEGO--([ BUSINESS WIRE ])--Sept. 28, 2010--Senomyx, Inc. (NASDAQ:SNMX), a leading company focused on using proprietary taste receptor technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Mary Ann Gray, Ph.D., has joined the Companya™s Board of Directors. Dr. Gray has extensive experience in both the financial community and the biotechnology industry.
"Mary Ann Gray has a strong background as an equity research analyst, strategic advisor, scientist, and member of Boards of Directors of public companies"
aMary Ann Gray has a strong background as an equity research analyst, strategic advisor, scientist, and member of Boards of Directors of public companies,a said Kent Snyder, President, Chief Executive Officer, and Chairman of the Board of the Company. aWe believe Senomyx will benefit from her insights and expertise as we continue to advance our discovery and development programs and enter into new collaborations with world-class food, beverage, and ingredient supply company partners.a
Mary Ann Gray, Ph.D., is currently President of Gray Strategic Advisors, LLC, which provides strategic consulting services to the biotechnology industry. Dr. Gray also serves on the Boards of Directors of Dyax Corp. and Acadia Pharmaceuticals, both publicly-held companies, and Apthera Inc., a privately held company. She is the Chairman of the Audit Committee and a member of the Compensation Committee at Acadia, and Lead Director and a member of the Audit Committee at Dyax. During the past five years, Dr. Gray also served on the Boards of Directors of two additional public companies. From 1999 to 2003, Dr. Gray was Senior Analyst and Portfolio Manager for the Federated Kaufmann Fund. Prior to 1999, Dr. Gray led biotechnology equity research groups at Raymond James & Associates, Warburg Dillon Read, and Kidder Peabody for an aggregate of nine years. Dr. Gray holds a Ph.D. degree in pharmacology from the University of Vermont, where she focused on novel chemotherapeutic agents for the treatment of cancer.
About Senomyx, Inc. ([ www.senomyx.com ])
Senomyx is a leading company using proprietary [ taste receptor ] technologies to discover and develop [ novel flavor ingredients ] in the savory, sweet, salt, bitter, and cooling areas. The Company has [ product discovery and development collaborations ] with global food, beverage, and ingredient supply companies, some of which are currently marketing products that contain Senomyxa™s flavor ingredients. For more information, please visit [ www.senomyx.com ].
